Skip to Content

nGL 12.5 (Movantik 12.5 mg)

Generic Name: naloxegol

Pill with imprint nGL 12.5 is Purple, Elliptical / Oval and has been identified as Movantik 12.5 mg. It is supplied by AstraZeneca Pharmaceuticals LP.

Movantik is used in the treatment of opioid-induced constipation; constipation, chronic; constipation, drug induced and belongs to the drug class peripheral opioid receptor antagonists. Risk cannot be ruled out during pregnancy. Movantik 12.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for nGL 12.5

Movantik 12.5 mg nGL 12.5

Movantik

Generic Name:
naloxegol
Imprint:
nGL 12.5
Strength:
12.5 mg
Color:
Purple
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Peripheral opioid receptor antagonists
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
AstraZeneca Pharmaceuticals LP
National Drug Code (NDC):
00310-1969

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide